MyFinsight
Home
Blog
About
Contact
Download
Download image
Decrease in cash and cash
equivalents
-$16,461K
Stock-based compensation
expense
$6,641K
Depreciation
$1,407K
Income taxes
$1,190K
Provision for inventory
$1,032K
Gain on sale of assets
-$904K
Accounts payable
$745K
Non-cash operating lease
cost
$464K
Deferred income taxes
$108K
Notes receivable
$192K
Net cash used in
financing activities
-$10,347K
Net cash used in
operating activities
-$4,846K
Net cash used in by
investing activities
-$1,239K
Exchange rate impact on
cash
-$29K
Canceled cashflow
$12,491K
Canceled cashflow
$192K
Repurchases of common stock
$8,690K
Cash paid for tax
withheld on vested...
$1,657K
Inventories
$5,407K
Purchases of property and
equipment
$1,431K
Net loss
-$5,056K
Accounts receivable
$2,180K
Prepaid expenses, other
current and long-term...
$1,728K
Accrued expenses, other
current and long-term...
-$1,339K
something is missing
-$956K
Operating lease
liabilities
-$468K
Interest income on notes
receivable
$179K
Provision for credit
losses
-$24K
Back
Back
Cash Flow
Anika Therapeutics, Inc. (ANIK)
Anika Therapeutics, Inc. (ANIK)
source: myfinsight.com